drugset / Trial / NCT03411252

Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study

NCT03411252

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study evaluates whether a medication called mirabegron is better than placebo (sugar pill) in helping patients with achalasia swallow better. Each patient will receive either mirabegron or the placebo for 4 weeks followed by the opposite medication. Each patient will complete several surveys and undergo several tests to determine if the mirabegron is helping reduce the pressures in the esophagus (swallowing tube).

Timeline

Start
2018-02-15
Primary completion
2019-12-15
Completion
2019-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified 50 mg Oral

Indications